AU2021238639B2 - Ginsenoside compositions - Google Patents
Ginsenoside compositionsInfo
- Publication number
- AU2021238639B2 AU2021238639B2 AU2021238639A AU2021238639A AU2021238639B2 AU 2021238639 B2 AU2021238639 B2 AU 2021238639B2 AU 2021238639 A AU2021238639 A AU 2021238639A AU 2021238639 A AU2021238639 A AU 2021238639A AU 2021238639 B2 AU2021238639 B2 AU 2021238639B2
- Authority
- AU
- Australia
- Prior art keywords
- ginsenosides
- extract
- composition
- weight
- acute
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Oncology (AREA)
- Psychology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2004121.6A GB202004121D0 (en) | 2020-03-20 | 2020-03-20 | Improved compositions |
| GB2004121.6 | 2020-03-20 | ||
| GB2005288.2 | 2020-04-09 | ||
| GBGB2005288.2A GB202005288D0 (en) | 2020-04-09 | 2020-04-09 | Improved compositions |
| PCT/EP2021/056788 WO2021185890A1 (en) | 2020-03-20 | 2021-03-17 | Ginsenoside compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2021238639A1 AU2021238639A1 (en) | 2022-09-15 |
| AU2021238639B2 true AU2021238639B2 (en) | 2026-06-25 |
Family
ID=75108332
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2021238639A Active AU2021238639B2 (en) | 2020-03-20 | 2021-03-17 | Ginsenoside compositions |
| AU2021238643A Pending AU2021238643A1 (en) | 2020-03-20 | 2021-03-17 | Ginsenoside compositions |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2021238643A Pending AU2021238643A1 (en) | 2020-03-20 | 2021-03-17 | Ginsenoside compositions |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20230124503A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4121061A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7808042B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN115315264A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2021238639B2 (cg-RX-API-DMAC7.html) |
| BR (2) | BR112022015826A2 (cg-RX-API-DMAC7.html) |
| CA (2) | CA3174699A1 (cg-RX-API-DMAC7.html) |
| WO (2) | WO2021185897A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230124503A1 (en) * | 2020-03-20 | 2023-04-20 | Givaudan Sa | Ginsenoside compositions |
| JP2023161983A (ja) * | 2022-04-26 | 2023-11-08 | 石川県公立大学法人 | サポニンを含む酪酸産生菌増殖能向上組成物、腸内常在菌増殖能向上組成物、乳酸菌増殖能向上組成物及びビフィズス菌増殖能向上組成物 |
| CN117224553B (zh) * | 2023-11-02 | 2025-08-12 | 浙江大学 | 人参皂苷Rg3在制备治疗或预防肠道病毒感染的药物中的应用 |
| CN117752706B (zh) * | 2023-12-20 | 2025-10-14 | 浙江天皇药业有限公司 | 西洋参炮制品在制备治疗甲状腺功能减退症药物中的应用 |
| WO2025261873A1 (en) | 2024-06-20 | 2025-12-26 | Givaudan Sa | Improvements in or relating to compounds |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150306119A1 (en) * | 2009-05-04 | 2015-10-29 | Naturex, S.A. | Application of american ginseng to enhance neurocognitive function |
| CN109432304A (zh) * | 2018-12-03 | 2019-03-08 | 杭州胡庆余堂药业有限公司 | 一种含铁皮石斛组合物在药物制备中的应用 |
| CN110613802A (zh) * | 2018-06-20 | 2019-12-27 | 珠海岐微生物科技有限公司 | 白茅根大黄炭三七组合物及其在调节肠道微生物中的用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040202731A1 (en) * | 2003-04-08 | 2004-10-14 | Gow Robert T. | Rosmarinic acid composition |
| US20100278944A1 (en) * | 2009-05-04 | 2010-11-04 | Naturex, S.A. | Application of american ginseng to enhance neurocognitive function |
| KR102200012B1 (ko) * | 2013-04-02 | 2021-01-08 | (주)아모레퍼시픽 | 인삼열매 추출물을 포함하는 뇌 활성화 조성물 |
| US10456436B2 (en) * | 2013-11-04 | 2019-10-29 | Wen Luan Wendy Hsiao | Use of herbal saponins to regulate gut microflora |
| BR112020000963A2 (pt) | 2017-07-18 | 2020-07-14 | Senescence Life Sciences Pte. Ltd. | composições e métodos para o tratamento e prevenção de declínio cognitivo e conservação da função neuronal |
| US20230124503A1 (en) | 2020-03-20 | 2023-04-20 | Givaudan Sa | Ginsenoside compositions |
-
2021
- 2021-03-17 US US17/905,849 patent/US20230124503A1/en active Pending
- 2021-03-17 WO PCT/EP2021/056803 patent/WO2021185897A1/en not_active Ceased
- 2021-03-17 EP EP21712999.8A patent/EP4121061A1/en active Pending
- 2021-03-17 BR BR112022015826A patent/BR112022015826A2/pt unknown
- 2021-03-17 CA CA3174699A patent/CA3174699A1/en active Pending
- 2021-03-17 AU AU2021238639A patent/AU2021238639B2/en active Active
- 2021-03-17 BR BR112022016241A patent/BR112022016241A2/pt unknown
- 2021-03-17 CN CN202180022225.5A patent/CN115315264A/zh active Pending
- 2021-03-17 WO PCT/EP2021/056788 patent/WO2021185890A1/en not_active Ceased
- 2021-03-17 CA CA3174698A patent/CA3174698A1/en active Pending
- 2021-03-17 CN CN202180022249.0A patent/CN115315266A/zh active Pending
- 2021-03-17 US US17/905,868 patent/US20230129389A1/en active Pending
- 2021-03-17 EP EP21713906.2A patent/EP4121076A1/en active Pending
- 2021-03-17 JP JP2022555990A patent/JP7808042B2/ja active Active
- 2021-03-17 AU AU2021238643A patent/AU2021238643A1/en active Pending
- 2021-03-17 JP JP2022556000A patent/JP7850670B2/ja active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150306119A1 (en) * | 2009-05-04 | 2015-10-29 | Naturex, S.A. | Application of american ginseng to enhance neurocognitive function |
| CN110613802A (zh) * | 2018-06-20 | 2019-12-27 | 珠海岐微生物科技有限公司 | 白茅根大黄炭三七组合物及其在调节肠道微生物中的用途 |
| CN109432304A (zh) * | 2018-12-03 | 2019-03-08 | 杭州胡庆余堂药业有限公司 | 一种含铁皮石斛组合物在药物制备中的应用 |
Non-Patent Citations (4)
| Title |
|---|
| ANDREW SCHOLEY ET AL: "Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study", PSYCHOPHARMACOLOGY, SPRINGER, BERLIN, DE, vol. 212(3), 345 -356 * |
| Arring, N.M., et al., Ginseng as a treatment for fatigue: a systematic review, 2018, J Alt Comp Med, 24(7):624-633, 10 pages. . (Year: 2018) * |
| BARTON D. L. ET AL: "Wisconsin Ginseng (Panax quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind Trial, N07C2" 105 (16) pages 1230-1238 * |
| MANCUSO CESARE ET AL: "Panax ginseng and Panax quinquefolius : From pharmacology to toxicology", FOOD AND CHEMICAL TOXICOLOGY, vol. 107, 1 September 2017 (2017-09-01), GB, pages 362 - 372, * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4121061A1 (en) | 2023-01-25 |
| WO2021185897A1 (en) | 2021-09-23 |
| US20230129389A1 (en) | 2023-04-27 |
| AU2021238643A1 (en) | 2022-10-20 |
| WO2021185890A1 (en) | 2021-09-23 |
| US20230124503A1 (en) | 2023-04-20 |
| BR112022015826A2 (pt) | 2022-10-04 |
| CA3174699A1 (en) | 2021-09-23 |
| CN115315264A (zh) | 2022-11-08 |
| CA3174698A1 (en) | 2021-09-23 |
| EP4121076A1 (en) | 2023-01-25 |
| BR112022016241A2 (pt) | 2022-10-11 |
| JP7850670B2 (ja) | 2026-04-23 |
| JP2023518064A (ja) | 2023-04-27 |
| JP2023519189A (ja) | 2023-05-10 |
| JP7808042B2 (ja) | 2026-01-28 |
| CN115315266A (zh) | 2022-11-08 |
| AU2021238639A1 (en) | 2022-09-15 |